Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 40 of 40 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
 |
Company AegisCN LLC | Activity: Research and Development | Company Description AegisCN develops technologies and treatments targeting neurological diseases and inflammation. | Location Durham |
| |
Company Aestas Pharma Inc. | Activity: Research and Development | Company Description Aestas Pharma develops novel diagnostic imaging and disease-modifying therapeutic agents to enable the detection, early treatment and reversal of Alzheimer’s disease when clinical signs are not yet pronounced. | Location Durham |
| |
Company Arrivo BioVentures LLC | Activity: Research and Development | Company Description Arrivo BioVentures accelerates biologics and small molecules from IND readiness through a clinical proof of concept, with biologics in development for dermatologic conditions. | Location Morrisville |
| |
Company AskBio | Activity: Research and Development | Company Description Asklepios BioPharmaceutical (AskBio) uses adeno-associated virus (AAV) technology to develop and manufacture gene therapies for rare diseases and other genetic disorders. | Location Research Triangle Park |
| |
Company Atrium Health Division of Therapeutic Research and Development | Activity: Research and Development | Company Description The Division of Therapeutic Research and Development at Atrium Health conducts clinical studies, patient-focused translational research and outcomes research. | Location Charlotte |
| |
Company Avicenna Biosciences Inc. | Activity: Research and Development | Company Description Avicenna Biosciences is a drug development company using machine learning-enhanced medicinal chemistry to accelerate the lead-to-candidate optimization process for small molecule drug development. | Location Durham |
| |
Company Black Swan Pharmaceuticals Inc. | Activity: Research and Development | Company Description Black Swan Pharmaceuticals is developing preclinical gene targeting therapeutics for motor neurone disease (MND) / Amyotrophic Lateral Sclerosis (ALS) and other neurological disorders. | Location Wake Forest |
| |
Company Centaur Bio Inc. | Activity: Research and Development | Company Description Centaur Bio develops technology that facilitates precision drug delivery, which will potentially improve treatments for solid tumors and CNS disorders. | Location Charlotte |
| |
Company CLAIRIgene LLC | Activity: Research and Development | Company Description CLAIRIgene develops viral vector platforms for gene therapy products to treat central nervous system diseases and conditions. | Location Durham |
| |
Company Cognosci Inc. | Activity: Research and Development | Company Description Cognosci develops neurorestorative therapies for Alzheimer's disease, multiple sclerosis, traumatic brain injury, nerve crush and other disease and trauma indications. | Location Durham |
| |
Company DelAQUA Pharmaceuticals Inc. | Activity: Research and Development | Company Description DelAQUA Pharmaceuticals is developing technology to enhance the solubility and stability of drugs and drug candidates and to improve their efficacy and safety. | Location Chapel Hill |
| |
Company ENVIGEN Pharmaceuticals Inc. | Activity: Research and Development | Company Description ENVIGEN develops classes of small drug-like molecules to treat life-threatening diseases including cancer, HIV/AIDS and neurological disorders. | Location Durham |
| |
Company Generys Biopharmaceuticals Corp. | Activity: Research and Development | Company Description Generys BioPharmaceuticals develops drugs, formulations and generics for unmet medical needs. Generys also offers therapeutic pipeline portfolio consulting and management services on a contract basis. | Location Chapel Hill |
| |
Company GSK (Durham) | Activity: Research and Development | Company Description GSK develops and manufactures vaccines and medicines, with a focus on science related to the immune system, human genetics and advanced technologies. | Location Durham |
| |
Company Karamedica Inc. | Activity: Research and Development | Company Description Karamedica has developed a plasma treatment of batch quantities of chitosan and other biopolymers in order to lower endotoxin levels. Karamedica is also currently developing a nanoparticle therapy for cerebral amyloid angiopathy. | Location Raleigh |
| |
Company Krenitsky Pharmaceuticals Inc. | Activity: Research and Development | Company Description Krenitsky Pharmaceuticals discovers and develops drug candidates, with a focus on disorders of the nervous system. | Location Chapel Hill |
| |
Company LadeRx LLC | Activity: Research and Development | Company Description LadeRx is developing new technology for diagnostic radiology. | Location Durham |
| |
Company LVM Biosciences Inc. | Activity: Research and Development | Company Description LVM Biosciences develops therapeutics for epilepsy, stroke, anxiety, migraine, and pain. | Location Chapel Hill |
| |
Company Merz Therapeutics | Activity: Research and Development | Company Description Merz Therapeutics develops and commercializes neurological therapeutic treatment solutions for patients who suffer from movement disorders and neurological health conditions. | Location Raleigh |
| |
Company Mind Medicine Inc. | Activity: Research and Development | Company Description Mind Medicine is a clinical-stage biopharmaceutical company developing products using the therapeutic potential of psychedelics to treat brain health disorders, with a focus on psychiatry, addiction, pain and neurology. | Location Durham |
| |
Company NeuroGT Inc. | Activity: Research and Development | Company Description NeuroGT is developing gene therapy products to treat rare neurogenetic diseases. | Location Chapel Hill |
| |
Company Olfax LLC | Activity: Research and Development | Company Description Olfax Medical is developing nasally administered therapeutics to help patients avoid the harmful and addictive side effects of systemic pharmaceuticals. | Location Asheville |
| |
Company Osmotica Pharmaceutical Corp. | Activity: Research and Development | Company Description Osmotica Pharmaceutical specializes in drug-delivery technologies and neurology-based therapies, including a treatment for Parkinson's disease. | Location Wilmington |
| |
Company Pfizer Inc. (Durham) | Activity: Research and Development | Company Description Pfizer develops gene therapies to treat rare genetic central nervous system (CNS) and neuromuscular diseases. Pfizer's BioTherapeutics Pharmaceutical Sciences site in Durham houses clinical manufacturing space and analytical research development laboratories. | Location Durham |
| |
Company Pinnacle Hill LLC | Activity: Research and Development | Company Description Pinnacle Hill, a joint venture of UNC-Chapel Hill and Deerfield Management, works with faculty to accelerate the development of their research projects to discover and develop new drugs and therapies for unmet needs. | Location Chapel Hill |
| |
Company Praetego Inc. | Activity: Research and Development | Company Description Praetego is preclinical stage pharmaceutical company committed to improving health outcomes by addressing chronic diseases of aging, starting with Alzheimer’s Disease. Praetego’s novel small molecules inhibit a systemic driver of oxidative stress at the initiation of pathology. | Location Research Triangle Park |
| |
Company Regennova Inc. | Activity: Research and Development | Company Description Regennova develops therapeutics for inflammatory diseases and neurological disorders, including cerebral stroke, traumatic brain injury, Alzheimer's and sepsis. | Location Durham |
| |
Company Revivo Therapeutics Inc. | Activity: Research and Development | Company Description Revivo Therapeutics is a clinical stage company developing therapies for cognitive dysfunction and neuroprotection. | Location Durham |
| |
Company Roivant Sciences Inc. | Activity: Research and Development | Company Description Roivant Sciences acquires drug candidates or partners with the biopharma industry to complete the clinical development of shelved product candidates. Therapeutic areas include neurology, dermatology, hepatology, oncology, endocrinology and rare disease. | Location Durham |
| |
Company Sentiens LLC | Activity: Research and Development | Company Description Sentiens develops nutraceutical products targeting addictive behavior. | Location Charlotte |
| |
Company SiNON Nano Sciences Inc. | Activity: Research and Development | Company Description SiNON is developing technology to treat neurological diseases by increasing the ability of drugs to cross the blood brain barrier (BBB). | Location Durham |
| |
Company SpringWorks Therapeutics LLC | Activity: Research and Development | Company Description SpringWorks Therapeutics develops standalone and combination therapies with a focus on rare diseases and oncology, including plexiform neurofibroma, desmoid tumors, RAS/RAF mutant solid tumors and CNS disorders. Its initial portfolio is from Pfizer. | Location Durham |
| |
Company T3D Therapeutics Inc. | Activity: Research and Development | Company Description T3D Therapeutics is developing a disease-modifying drug therapy for Alzheimer’s disease that may improve multiple disease defects. T3D is also targeting treatments for other neurodegenerative diseases including Huntington's Disease. | Location Research Triangle Park |
| |
Company Tellus Therapeutics Inc. | Activity: Research and Development | Company Description Tellus Therapeutics is developing novel small molecules derived from human maternal breast milk for the treatment of newborns with perinatal brain injury. | Location Research Triangle Park |
| |
Company Tenax Therapeutics Inc. | Activity: Research and Development | Company Description Tenax Therapeutics develops and commercializes pharmaceutical products for the critical care market. | Location Morrisville |
| |
Company TregTherapeutics Inc. | Activity: Research and Development | Company Description TregTherapeutics develops tolerogenic therapies to treat autoimmune disease. The approach uses endogenous antigens to personalize therapy for any patient and/or disease. | Location Chapel Hill |
| |
Company UCB Biosciences Inc. | Activity: Research and Development | Company Description UCB Biosciences develops therapeutics for the treatment of severe, life-threatening neurological and inflammatory diseases, including epilepsy, Parkinson's disease, rheumatoid arthritis, Crohn's disease, psoriatic arthritis, lupus and osteoporosis. | Location Morrisville |
| |
Company vTv Therapeutics LLC | Activity: Research and Development | Company Description vTv Therapeutics is a clinical-stage biopharmaceutical company developing orally administered small molecule drug candidates to fill significant unmet medical needs in Alzheimer's disease (AD), diabetes and inflammatory disorders. | Location High Point |
| |
Company Zarbio LLC | Activity: Research and Development | Company Description Zarbio develops pathophysiology-based treatments for neurodegenerative diseases such as Alzheimer's disease. | Location Chapel Hill |
| |
Company Zinfandel Pharmaceuticals Inc. | Activity: Research and Development | Company Description Zinfandel Pharmaceuticals uses pharmacogenetics to improve prediction of risk for Alzheimer’s disease and facilitate the development of effective therapies. | Location Chapel Hill |